The Alzheimer’s medication Aduhelm is being discontinued by drugmaker Biogen as it shifts resources to its other Alzheimer’s medication, Leqembi, and developing other treatments, the company ...

Biogen's difficult launch of controversial Alzheimer's therapy Aduhelm has been made even harder ... that Biogen and Eisai will have to start a brand new clinical trial of the drug in order ...